Evaluating discovery rate of Cτ and indices for intermediate disease that can progress or regress. 1000 simulation data sets of 150 subjects were used. 10 candidate predictors are evaluated: 5 correlated and 5 independent of the disease process. Time to progression and first regression are 69% and 34% right-censored, respectively. For Cτ, only disease progression was used. The index uses both disease progression and regression events with outcome-specific weights of 1 and 0.75, respectively. Both indices were evaluated at τ = 25. Negative and positive signs for the bias indicates underestimation and overestimation, respectively. ESD is the empirical standard deviation; ASE is the asymptotic standard error; CP is the coverage probability. False discovery rate (FDR) is defined as the number of independent predictors that reject H0 divided by the number of all predictors that reject H0, averaged over 1000 simulation runs. The null hypothesis is H0 : Cτ = 0.5 or H0 : = 0.5.